CN108226470A - A kind of method that embryo's integrality is kept in body early embryo histogenic immunity group - Google Patents
A kind of method that embryo's integrality is kept in body early embryo histogenic immunity group Download PDFInfo
- Publication number
- CN108226470A CN108226470A CN201810021505.4A CN201810021505A CN108226470A CN 108226470 A CN108226470 A CN 108226470A CN 201810021505 A CN201810021505 A CN 201810021505A CN 108226470 A CN108226470 A CN 108226470A
- Authority
- CN
- China
- Prior art keywords
- embryo
- phosphate buffer
- polyvinylpyrrolidone
- 5min
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001161 mammalian embryo Anatomy 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 22
- 230000003037 histogenic effect Effects 0.000 title claims 3
- 230000036039 immunity Effects 0.000 title claims 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 47
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 46
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 46
- 210000002257 embryonic structure Anatomy 0.000 claims abstract description 32
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 30
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000003364 immunohistochemistry Methods 0.000 claims abstract description 13
- 229930040373 Paraformaldehyde Natural products 0.000 claims abstract description 10
- 229920002866 paraformaldehyde Polymers 0.000 claims abstract description 10
- 229920004890 Triton X-100 Polymers 0.000 claims abstract description 9
- 239000013504 Triton X-100 Substances 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 230000008823 permeabilization Effects 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 3
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims 1
- 238000000338 in vitro Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 230000002055 immunohistochemical effect Effects 0.000 abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 7
- 230000001776 parthenogenetic effect Effects 0.000 description 6
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001109 blastomere Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/305—Fixative compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明公开了一种早期胚胎组织的免疫组化中保持胚胎完整性的方法,属于动物生物技术领域。该方法采用聚乙烯吡咯烷酮溶液添加于早期胚胎免疫组化所用磷酸盐缓冲液、多聚甲醛、Triton X‑100、双氧水中,防止胚胎贴壁,在整个免疫组化过程中可保持胚胎完整性,提高免疫组化效果。本发明所采用的技术方案主要针对体外胚胎,在常规免疫组化步骤基础上进行了调整,调整了组织处理部分试剂成分,有效提高了免疫组化效果。本发明针对免疫组化技术存在的不足,扩大了应用范围,具有操作简便,生产成本低等优点。The invention discloses a method for maintaining embryo integrity in immunohistochemistry of early embryo tissue, and belongs to the field of animal biotechnology. In this method, polyvinylpyrrolidone solution is added to phosphate buffer, paraformaldehyde, Triton X‑100, and hydrogen peroxide used in early embryo immunohistochemistry to prevent embryos from adhering to the wall and maintain embryo integrity throughout the immunohistochemistry process. Improve the effect of immunohistochemistry. The technical solution adopted in the present invention is mainly aimed at in vitro embryos, and is adjusted on the basis of conventional immunohistochemical steps, and the components of some reagents for tissue processing are adjusted, which effectively improves the effect of immunohistochemistry. The invention aims at the shortcomings of the immunohistochemical technique, expands the scope of application, and has the advantages of simple and convenient operation, low production cost and the like.
Description
技术领域technical field
本发明涉及一种在早期胚胎组织免疫组化中保持胚胎完整性的方法,属于动物生物技术领域。The invention relates to a method for maintaining embryo integrity in early embryo tissue immunohistochemistry, and belongs to the field of animal biotechnology.
背景技术Background technique
聚乙烯吡咯烷酮简称PVP,是N-乙烯基-2-吡咯烷酮发生聚合生产的高分子化合物。其是一种白色有吸湿性的粉末,无臭或微臭,可溶于水、乙醇、氯仿和多数有机溶剂,不溶于乙醚,毒性较小。聚乙烯吡咯烷酮可以单体乙烯基吡咯烷酮为原料,通过本体聚合、溶液聚合等方法合成。作为一种合成水溶性高分子化合物,具有水溶性高分子化合物一般性质,胶体保护作用、成膜性、粘结性、吸湿性、增溶或凝聚作用。其溶液毒性很低、无生理形容性。在医药、食品、化妆品等领域广泛应用。Polyvinylpyrrolidone, referred to as PVP, is a polymer compound produced by the polymerization of N-vinyl-2-pyrrolidone. It is a white hygroscopic powder, odorless or slightly odorous, soluble in water, ethanol, chloroform and most organic solvents, insoluble in ether, and less toxic. Polyvinylpyrrolidone can be synthesized by monomer vinylpyrrolidone through bulk polymerization, solution polymerization and other methods. As a synthetic water-soluble polymer compound, it has the general properties of water-soluble polymer compounds, colloidal protection, film-forming, cohesive, hygroscopic, solubilizing or coagulating effects. Its solution has very low toxicity and is non-physiologically descriptive. It is widely used in medicine, food, cosmetics and other fields.
体外胚胎培养为探究早期胚胎发育提供了必要的材料,是一种生殖生物技术,其加快了畜禽遗传改良,在动物育种中有着重要意义。这一技术也是哺乳动物胚胎工程研究中的一个重要工具,其为探究体内胚胎发育机制、改良胚胎发育质量奠定了良好的基础,是体内胚胎系统的一个有效的反映,也是发育生物学和新兴生物技术中一个重要的研究技术。但在培养过程中,胚胎容易贴壁,在换培养液移动胚胎时会使其囊壁破裂,所以在整个培养过程中将丢失很多胚胎,建设了试验样本。利用聚乙烯吡咯烷酮水溶性、粘性及低毒性,在胚胎培养液中添加聚乙烯吡咯烷酮,可降低胚胎贴壁,保持胚胎的完整性,基于此,在胚胎免疫组化试验中,所用试剂添加一定浓度的聚乙烯吡咯烷酮,亦可减少胚胎贴壁,保持胚胎完整性,增加试验效果。In vitro embryo culture provides necessary materials for exploring early embryo development. It is a reproductive biotechnology that accelerates the genetic improvement of livestock and poultry, and is of great significance in animal breeding. This technology is also an important tool in the research of mammalian embryo engineering. It has laid a good foundation for exploring the mechanism of embryonic development in vivo and improving the quality of embryonic development. An important research technique in technology. However, during the culture process, the embryos are easy to adhere to the wall, and the capsule wall will be broken when the culture medium is changed to move the embryos, so many embryos will be lost during the whole culture process, and a test sample was constructed. Taking advantage of the water solubility, viscosity and low toxicity of polyvinylpyrrolidone, adding polyvinylpyrrolidone to the embryo culture medium can reduce the adhesion of the embryo and maintain the integrity of the embryo. Based on this, in the embryo immunohistochemical test, the reagents used add a certain concentration The polyvinylpyrrolidone can also reduce the adherence of embryos, maintain the integrity of embryos, and increase the test effect.
本方法在胚胎免疫组化中的应用,建立了可行的试验方法,操作简便易行,试验效果明显,为胚胎工程研究提供了切实可行的依据。The application of this method in embryo immunohistochemistry establishes a feasible test method, which is simple and easy to operate, and the test effect is obvious, which provides a practical basis for embryo engineering research.
发明内容Contents of the invention
技术问题 本发明的目的在于提供一种在早期胚胎组织免疫组化中保持胚胎完整性的方法。Technical Problem The object of the present invention is to provide a method for maintaining embryo integrity in immunohistochemistry of early embryo tissue.
技术方案Technical solutions
1、一种在早期胚胎组织免疫组化中保持胚胎完整性的方法,包括以下步骤:1. A method for maintaining embryo integrity in early embryo tissue immunohistochemistry, comprising the following steps:
1)溶液配制:4%多聚甲醛,0.5% Triton X-100,双氧水20%聚乙烯吡咯烷酮储存溶液和0.1μg/mL4',6-二脒基-2-苯基吲哚均用PH范围为7.2-7.4的0.01mol/L磷酸盐缓冲液稀释;且免疫组化用4%多聚甲醛,0.5% Triton X-100、双氧水和磷酸盐缓冲液中均加入聚乙烯吡咯烷酮储存液,添加浓度分别为2%、4%、6%、8%、10%。1) Solution preparation: 4% paraformaldehyde, 0.5% Triton X-100, hydrogen peroxide, 20% polyvinylpyrrolidone storage solution and 0.1μg/mL 4', 6-diamidino-2-phenylindole are all used in a pH range of 7.2-7.4 was diluted with 0.01mol/L phosphate buffer; and 4% paraformaldehyde, 0.5% Triton X-100, hydrogen peroxide and phosphate buffer were added to the stock solution of polyvinylpyrrolidone for immunohistochemistry. 2%, 4%, 6%, 8%, 10%.
2)胚胎清洗:在显微镜下,将体外培育的2细胞期、4细胞期、8细胞期和16细胞期的孤雌胚胎、孤雄胚胎或体外受精胚胎从培养液中捡出,用38.5℃下预热的加入聚乙烯吡咯烷酮的0.01mol/L磷酸盐缓冲液漂洗3 次,每次5min;2) Embryo washing: Under a microscope, pick out the parthenogenetic embryos, androgenetic embryos or in vitro fertilized embryos cultivated in vitro at the 2-cell stage, 4-cell stage, 8-cell stage, and 16-cell stage from the culture medium, and wash them at 38.5°C. Rinse with preheated 0.01mol/L phosphate buffer saline with polyvinylpyrrolidone for 3 times, 5min each time;
3)胚胎固定:用加入聚乙烯吡咯烷酮溶液的4%的多聚甲醛在室温下固定胚胎1h,然后用预热的加入聚乙烯吡咯烷酮溶液的磷酸盐缓冲液漂洗3次,每次5min;3) Embryo fixation: fix the embryos with 4% paraformaldehyde added to polyvinylpyrrolidone solution at room temperature for 1 hour, and then rinse with preheated phosphate buffer solution added to polyvinylpyrrolidone solution 3 times, 5 minutes each time;
4)通透:用加入聚乙烯吡咯烷酮的0.5% Triton X-100室温透化30 min,然后用预热的加入聚乙烯吡咯烷酮溶液的磷酸盐缓冲液漂洗3次,每次5 min;4) Permeabilization: permeabilize with 0.5% Triton X-100 with polyvinylpyrrolidone at room temperature for 30 min, then rinse with preheated phosphate buffer solution with polyvinylpyrrolidone solution for 3 times, 5 min each time;
5)去除内源性过氧化物酶:用加入聚乙烯吡咯烷酮的0.01mol/L磷酸盐缓冲液配置新鲜的3% H2O2,室温封闭5~10min,用预热的含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3 次,每次5 min;5) Remove endogenous peroxidase: prepare fresh 3% H 2 O 2 with 0.01mol/L phosphate buffer solution added with polyvinylpyrrolidone, block at room temperature for 5-10min, and use preheated polyvinylpyrrolidone-containing Rinse with phosphate buffer 3 times, 5 min each time;
6)封闭:滴血清(与二抗同一来源)孵育,37℃封闭30 min;6) Blocking: Incubate with drops of serum (from the same source as the secondary antibody), and block for 30 min at 37°C;
7)一抗孵育:轻轻吸除封闭液,加按抗体说明用磷酸缓冲液稀释的一抗覆盖于胚胎中,将其放在湿盒中,4℃过夜;7) Primary antibody incubation: Remove the blocking solution gently, add the primary antibody diluted with phosphate buffer according to the antibody instruction to cover the embryo, put it in a wet box, and overnight at 4°C;
8)二抗孵育:用预热的含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3 次,每次5 min,加按抗体说明用磷酸缓冲液稀释的荧光标记二抗,37℃中避光孵育30 min;8) Secondary antibody incubation: wash with preheated phosphate buffer containing polyvinylpyrrolidone for 3 times, each time for 5 minutes, add fluorescently labeled secondary antibody diluted with phosphate buffer according to the antibody instruction, and incubate in the dark at 37°C for 30 min;
9)4',6-二脒基-2-苯基吲哚染核:二抗孵育后的胚胎用含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3次,每次5 min,取10μL 0.1μg/mL4',6-二脒基-2-苯基吲哚溶液于胚胎上,室温5min;9) Nuclei staining with 4',6-diamidino-2-phenylindole: The embryos incubated with the secondary antibody were rinsed 3 times with phosphate buffer containing polyvinylpyrrolidone for 5 minutes each time, and 10 μL of 0.1 μg/ Put mL4',6-diamidino-2-phenylindole solution on the embryo, room temperature for 5min;
10)封片:用含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3次,每次5 min,95%甘油封片,盖上盖玻片;10) Mounting: Rinse 3 times with phosphate buffered saline containing polyvinylpyrrolidone, 5 min each time, seal with 95% glycerol, and cover with a coverslip;
11)荧光观察:在共聚焦显微镜下观察荧光分布。11) Fluorescence observation: Observe the fluorescence distribution under a confocal microscope.
有益效果Beneficial effect
本发明提供了一种在早期胚胎组织免疫组化中保持胚胎完整性的方法。本发明具有以下优点:1)操作简便;2)针对性强;3)提高胚胎组织免疫组化效果。本发明方法和结果为开展与早期孤雌、孤雄或体外受精胚胎有关的生物学研究提供了新的研究技术。The present invention provides a method for maintaining embryonic integrity in immunohistochemistry of early embryonic tissue. The invention has the following advantages: 1) easy operation; 2) strong pertinence; 3) improving the immunohistochemical effect of embryonic tissue. The method and results of the invention provide a new research technology for carrying out biological research related to early parthenogenetic, parthenogenetic or in vitro fertilized embryos.
说明书附图Instructions attached
图1为孤雌胚胎发育过程;其中图a为2-4细胞期卵裂球;图b为4-16细胞期卵裂球。Figure 1 shows the development process of parthenogenetic embryos; Figure a shows the blastomeres at the 2-4 cell stage; Figure b shows the blastomeres at the 4-16 cell stage.
具体实施方式Detailed ways
下述实施例中所用方法如无特别说明均为常规方法,所述百分含量如无特别说明均为体积百分含量。The methods used in the following examples are conventional methods unless otherwise specified, and the percentages are volume percentages unless otherwise specified.
1、实施材料1. Implementation materials
体外构建的早期孤雌胚胎,包括卵裂前、2细胞胚胎、8细胞胚胎和16细胞胚胎。Early parthenogenetic embryos constructed in vitro, including precleavage, 2-cell embryos, 8-cell embryos and 16-cell embryos.
2、实施方法2. Implementation method
1)溶液配制:4%多聚甲醛,0.5% Triton X-100,双氧水20%聚乙烯吡咯烷酮储存溶液和0.1μg/mL 4',6-二脒基-2-苯基吲哚均用PH范围为7.2-7.4的0.01mol/L磷酸盐缓冲液稀释;且免疫组化用4%多聚甲醛,0.5% Triton X-100、双氧水和磷酸盐缓冲液中均加入聚乙烯吡咯烷酮储存液,添加浓度分别为2%、4%、6%、8%、10%;1) Solution preparation: 4% paraformaldehyde, 0.5% Triton X-100, hydrogen peroxide 20% polyvinylpyrrolidone storage solution and 0.1μg/mL 4',6-diamidino-2-phenylindole all use the pH range 7.2-7.4 0.01mol/L phosphate buffer dilution; and immunohistochemistry with 4% paraformaldehyde, 0.5% Triton X-100, hydrogen peroxide and phosphate buffer were added to polyvinylpyrrolidone stock solution, the added concentration 2%, 4%, 6%, 8%, 10% respectively;
2)胚胎清洗:在显微镜下,将体外培育的2细胞期、4细胞期、8细胞期和16细胞期的孤雌胚胎、孤雄胚胎或体外受精胚胎从培养液中捡出,用38.5℃下预热的含聚乙烯吡咯烷酮的0.01mol/L磷酸盐缓冲液漂洗3 次,每次5min;2) Embryo washing: Under a microscope, pick out the parthenogenetic embryos, androgenetic embryos or in vitro fertilized embryos cultivated in vitro at the 2-cell stage, 4-cell stage, 8-cell stage, and 16-cell stage from the culture medium, and wash them at 38.5°C. Rinse with preheated 0.01mol/L phosphate buffered saline containing polyvinylpyrrolidone 3 times, 5min each time;
3)胚胎固定:用含聚乙烯吡咯烷酮溶液的4%的多聚甲醛在室温下固定胚胎1h,然后用预热的含聚乙烯吡咯烷酮溶液的磷酸盐缓冲液漂洗3次,每次5min;3) Embryo fixation: fix the embryos with 4% paraformaldehyde containing polyvinylpyrrolidone solution at room temperature for 1 hour, then rinse with preheated phosphate buffer solution containing polyvinylpyrrolidone solution 3 times, 5 minutes each time;
4)通透:用含聚乙烯吡咯烷酮的0.5% Triton X-100室温透化30 min,然后用预热的含聚乙烯吡咯烷酮溶液的磷酸盐缓冲液漂洗3次,每次5 min;4) Permeabilization: Permeabilize with 0.5% Triton X-100 containing polyvinylpyrrolidone at room temperature for 30 min, then rinse with preheated phosphate buffer containing polyvinylpyrrolidone solution 3 times, 5 min each time;
5)去除内源性过氧化物酶:用含聚乙烯吡咯烷酮的0.01mol/L磷酸盐缓冲液配置新鲜的3% H2O2,室温封闭5~10min,用预热的含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3 次,每次5 min;5) Remove endogenous peroxidase: prepare fresh 3% H 2 O 2 with 0.01mol/L phosphate buffer containing polyvinylpyrrolidone, block at room temperature for 5-10min, and use preheated polyvinylpyrrolidone-containing Rinse with phosphate buffer 3 times, 5 min each time;
6)封闭:滴血清(与二抗同一来源)孵育,37℃封闭30 min;6) Blocking: Incubate with drops of serum (from the same source as the secondary antibody), and block for 30 min at 37°C;
7)一抗孵育:轻轻吸除封闭液,加1:100磷酸盐缓冲液稀释的抗MT1多克隆抗体覆盖于胚胎中,将其放在湿盒中,4℃过夜;7) Primary antibody incubation: gently aspirate the blocking solution, add 1:100 diluted anti-MT1 polyclonal antibody in phosphate buffer to cover the embryo, put it in a wet box, and overnight at 4°C;
8)二抗孵育:用含的聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3 次,每次5 min,加1:100磷酸盐缓冲液稀释的CY3标记羊抗兔荧光二抗,37℃中避光孵育30 min;8) Secondary antibody incubation: Rinse 3 times with phosphate buffer containing polyvinylpyrrolidone, 5 min each time, add CY3-labeled goat anti-rabbit fluorescent secondary antibody diluted 1:100 in phosphate buffer, and protect from light at 37°C Incubate for 30 min;
9)4',6-二脒基-2-苯基吲哚染核:二抗孵育后的胚胎用含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3次,每次5 min,取适量0.1μg/mL 4',6-二脒基-2-苯基吲哚于胚胎上,室温5min;9) Nuclear staining with 4',6-diamidino-2-phenylindole: After incubation with the secondary antibody, wash the embryos with phosphate buffer containing polyvinylpyrrolidone for 3 times, each time for 5 min, take an appropriate amount of 0.1 μg/ Put mL 4',6-diamidino-2-phenylindole on the embryo, room temperature for 5min;
10)封片:用含聚乙烯吡咯烷酮的磷酸盐缓冲液漂洗3次,每次5 min,95%甘油封片,盖上盖玻片;10) Mounting: Rinse 3 times with phosphate buffered saline containing polyvinylpyrrolidone, 5 min each time, seal with 95% glycerol, and cover with a coverslip;
11)荧光观察:在共聚焦显微镜下观察荧光分布。11) Fluorescence observation: Observe the fluorescence distribution under a confocal microscope.
3、处理效果3. Processing effect
体外胚胎在培养过程中容易贴壁,致使一些胚胎在一些试验操作过程中无法保证其完整性,而丢失许多胚胎。添加聚乙烯吡咯烷酮可以防止胚胎贴壁,利于试验中对胚胎的操作,保持胚胎完整性。表1显示,在免疫组化试验过程中,所用试剂中添加不同浓度聚乙烯吡咯烷酮溶液,胚胎完整性受到很大影响。随着添加的聚乙烯吡咯烷酮浓度增加,胚胎完整率逐渐增加,以8%聚乙烯吡咯烷酮溶液处理后的胚胎完整性是最高的,可达到95.24%;但当添加10% 聚乙烯吡咯烷酮溶液后,胚胎完整率下降到72%。由此可见,胚胎免疫组化试验中,添加8%的聚乙烯吡咯烷酮溶液,胚胎的完整率是最高的,增加了试验效率。Embryos in vitro are easy to adhere to the wall during the culture process, so some embryos cannot guarantee their integrity during some experimental operations, and many embryos are lost. Adding polyvinylpyrrolidone can prevent the embryo from sticking to the wall, which is beneficial to the operation of the embryo in the experiment and maintains the integrity of the embryo. Table 1 shows that during the immunohistochemical test, the integrity of the embryo was greatly affected by the addition of different concentrations of polyvinylpyrrolidone solutions to the reagents used. As the concentration of polyvinylpyrrolidone added increases, the integrity rate of embryos increases gradually, and the integrity of embryos treated with 8% polyvinylpyrrolidone solution is the highest, reaching 95.24%. The completion rate dropped to 72%. It can be seen that in the embryo immunohistochemical test, adding 8% polyvinylpyrrolidone solution, the integrity rate of the embryo is the highest, which increases the test efficiency.
表1 不同浓度聚乙烯吡咯烷酮溶液对胚胎完整性的影响Table 1 Effects of different concentrations of polyvinylpyrrolidone solutions on the integrity of embryos
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810021505.4A CN108226470A (en) | 2018-01-10 | 2018-01-10 | A kind of method that embryo's integrality is kept in body early embryo histogenic immunity group |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810021505.4A CN108226470A (en) | 2018-01-10 | 2018-01-10 | A kind of method that embryo's integrality is kept in body early embryo histogenic immunity group |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108226470A true CN108226470A (en) | 2018-06-29 |
Family
ID=62641665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810021505.4A Pending CN108226470A (en) | 2018-01-10 | 2018-01-10 | A kind of method that embryo's integrality is kept in body early embryo histogenic immunity group |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108226470A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110286019A (en) * | 2019-04-26 | 2019-09-27 | 青岛农业大学 | A Whole Embryo Immobilization Method for Membrane-Tipped Yolk Eggs |
CN111190001A (en) * | 2020-01-10 | 2020-05-22 | 苏州睿瀛生物技术有限公司 | Special diluent for immunohistochemical antibody and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608323A (en) * | 2012-03-26 | 2012-07-25 | 西北农林科技大学 | Method for analyzing embryo quality based on molecular immunoassay of mammalian blastulas |
CN103048470A (en) * | 2012-12-20 | 2013-04-17 | 山西医科大学 | Immunofluorescence histochemistry technology |
CN103651334A (en) * | 2013-12-26 | 2014-03-26 | 湖北医药学院 | Luciola praeusta Kiesenwetter embryo vitrification cryopreservation method |
CN104062426A (en) * | 2014-06-18 | 2014-09-24 | 兰州大学第一医院 | Overall embryo immunostaining kit as well as use method and application thereof |
CN104133068A (en) * | 2014-08-11 | 2014-11-05 | 环境保护部南京环境科学研究所 | Method for observing microtubule structure of cytoskeleton in liver tissue of animals |
CN106908294A (en) * | 2017-03-24 | 2017-06-30 | 漯河医学高等专科学校 | A kind of processing method of Pathologic specimen |
WO2017155869A1 (en) * | 2016-03-07 | 2017-09-14 | X-Zell Inc. | Compositions and methods for identifying rare cells |
-
2018
- 2018-01-10 CN CN201810021505.4A patent/CN108226470A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608323A (en) * | 2012-03-26 | 2012-07-25 | 西北农林科技大学 | Method for analyzing embryo quality based on molecular immunoassay of mammalian blastulas |
CN103048470A (en) * | 2012-12-20 | 2013-04-17 | 山西医科大学 | Immunofluorescence histochemistry technology |
CN103651334A (en) * | 2013-12-26 | 2014-03-26 | 湖北医药学院 | Luciola praeusta Kiesenwetter embryo vitrification cryopreservation method |
CN104062426A (en) * | 2014-06-18 | 2014-09-24 | 兰州大学第一医院 | Overall embryo immunostaining kit as well as use method and application thereof |
CN104133068A (en) * | 2014-08-11 | 2014-11-05 | 环境保护部南京环境科学研究所 | Method for observing microtubule structure of cytoskeleton in liver tissue of animals |
WO2017155869A1 (en) * | 2016-03-07 | 2017-09-14 | X-Zell Inc. | Compositions and methods for identifying rare cells |
CN106908294A (en) * | 2017-03-24 | 2017-06-30 | 漯河医学高等专科学校 | A kind of processing method of Pathologic specimen |
Non-Patent Citations (5)
Title |
---|
ERIKA M. MUNCH 等: "Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation", 《J ASSIST REPROD GENET》 * |
JUNJIU HUANG 等: "Telomere susceptibility to cigarette smoke-induced oxidative damage and chromosomal instability of mouse embryos in vitro", 《FREE RADICAL BIOLOGY & MEDICINE》 * |
天津市硅酸盐学会和天津水泥工业设计研究院 编: "《华北地区硅酸盐学会第八届学术技术交流会论文集》", 30 September 2005, 中国建材工业出版社 * |
董方言 主编: "《现代实用中药新剂型新技术》", 30 April 2001, 人民卫生出版社 * |
郭立达和陈鸣丽 主编: "《动物细胞分离培养》", 31 August 2015, 重庆大学出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110286019A (en) * | 2019-04-26 | 2019-09-27 | 青岛农业大学 | A Whole Embryo Immobilization Method for Membrane-Tipped Yolk Eggs |
CN110286019B (en) * | 2019-04-26 | 2021-10-15 | 青岛农业大学 | A kind of whole embryo fixation method of yolk egg with removed membrane end |
CN111190001A (en) * | 2020-01-10 | 2020-05-22 | 苏州睿瀛生物技术有限公司 | Special diluent for immunohistochemical antibody and preparation method thereof |
CN111190001B (en) * | 2020-01-10 | 2024-03-26 | 苏州睿瀛生物技术有限公司 | Special diluent for immunohistochemical antibody and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101554152B (en) | Frozen semen diluent and preparation method thereof | |
CA3046169C (en) | Mammalian cell cryopreservation liquid | |
CN104161036A (en) | Antifreeze agent and diluent for livestock semen refrigeration preservation and application thereof | |
KR20060032953A (en) | Cryopreservation of Stem Cells Derived from Human Blastocysts by Use of Closed Straw Vitrification Methods | |
CN103789263B (en) | Construction method of bastard halibut brain cell system | |
ES2703751T3 (en) | Formulation and method of passage and collection of pluripotent stem cells | |
CN108226470A (en) | A kind of method that embryo's integrality is kept in body early embryo histogenic immunity group | |
CH700956B1 (en) | Freezing preservation of human blastocyst-derived stem cells by closed vitrification method. | |
CN108588005A (en) | A kind of isolated culture method of duck folliculus ovarii film layer cell | |
CN111657266A (en) | Application of phloretin in preparation of porcine, sheep or cattle semen cryopreservation agent | |
CN106520681A (en) | In vitro culture solution and cryopreservation solution of Ietalurus Punetaus spermatogonial stem cells, and in vitro culture and cryopreservation method | |
CN103329889A (en) | Application of beta-carotene in preparation of pig sperm cryoprotectant | |
CN103999849B (en) | The antifreeze of the freezing preservation of a kind of mammal testis tissue and freeze-thaw method | |
CN101134772B (en) | Method for separating membrane protein of sucking sperm rear head and uses thereof | |
KR101979981B1 (en) | Equine Semen Diluent for Long Term Preservation | |
CN118256426A (en) | Complete culture medium for establishing oogonial stem cell line of Scorpio humilis and its application | |
CA2653905A1 (en) | Procedure for the preparation of unilamellar vesicles for cryopreservation and the culture of stem cells and embryos | |
Cockroft | A comparative and historical review of culture methods for vertebrates. | |
Boroda et al. | The first steps towards generating induced pluripotent stem cells from cryopreserved skin biopsies of marine mammals | |
CN104805053B (en) | Pearl rough gentian grouper kisses end tissue lines and its construction method, application | |
CN106834207A (en) | A kind of Shelled Turtle Trionyx Sinensis gonad cell is separated and extracorporeal culturing method | |
CN102258004B (en) | Method for preserving/culturing oocytes in vitro to inhibit oocytes from germinal vesicle breakdown | |
CN118853544A (en) | An efficient and standardized serum-free bovine oocyte in vitro maturation medium | |
CN108254547A (en) | A kind of fluorescence immunoassay group method of body early embryo tissue | |
CN118895242A (en) | An efficient and standardized serum-free bovine oocyte in vitro maturation solution and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180629 |
|
RJ01 | Rejection of invention patent application after publication |